Russia: digestives & intestinal remedies market revenue 2018-2029

The revenue in the 'Digestives & Intestinal Remedies' segment of the otc pharmaceuticals market in Russia was forecast to continuously increase between 2024 and 2029 by in total 14 million U.S. dollars (+7.42 percent). According to this forecast, in 2029, the indicator will have increased for the sixth consecutive year to 202.61 million U.S. dollars.

Find more information concerning the Philippines and Singapore.

The Statista Market Insights cover a broad range of additional markets.

Revenue of the digestives & intestinal remedies market in Russia from 2018 to 2029 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Citation formats